The aim of this study was to isolate Babesia canis soluble antigens and to investigate the effect of their conjugates with gold nanoparticles on the immunogenicity in laboratory animals.
A procedure was developed for isolating and purifying B. canis antigens. The isolated culture antigen of B. canis 495 was coupled to gold nanoparticles, and the conjugate was used to immunize laboratory mice.
Western blotting showed that the resultant antiserum specifically recognized the proteins of the B. canis strains isolated from naturally infected dogs. The antibody titer, the respiratory activity of peritoneal macrophages, the proliferative activity of splenocytes, and the production of cytokines were maximal when the animals were immunized with the antigen–nanoparticle conjugate emulsified in complete Freund’s adjuvant. Without adjuvant, the babesial antigen was weakly immunogenic.
Therefore, the use of gold nanoparticles as an antigen carrier induced a broad immune response involving both cellular and humoral responses. The antibodies raised by the proposed procedure are potentially effective at immunodetection of Babesia canis infections in dogs.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Adaszek Ł, Winiarczyk S (2011) In vitro cultivation of Babesia canis canis parasites isolated from dogs in Poland. Parasitol Res 108:1303–1307. https://doi.org/10.1007/s00436-010-2181-7
Azzar G, Radisson J, Got R (1990) Characterization and purification of culture-derived soluble glycoproteins of Babesia canis. Parasitol Res 76:578–580. https://doi.org/10.1007/BF00932565
Babeş V (1888) Sur l’hémoglobinurie bactérienne du boeuf. C R Acad Hebd Séances Acad Sci 107:692–694
Baneth G, Florin-Christensen M, Cardoso L, Schnittger L (2015) Reclassification of Theileria annae as Babesia vulpes sp. nov. Parasit Vectors 8:207. https://doi.org/10.1186/s13071-015-0830-5
Bernas T, Dobrucki JW (2000) The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC. Arch Biochem Biophys 380:108–116. https://doi.org/10.1006/abbi.2000.1907
Carabineiro SAC (2017) Applications of gold nanoparticles in nanomedicine: recent advances in vaccines. Molecules 22:857. https://doi.org/10.3390/molecules22050857
Comber JD, Bamezai A (2015) Gold nanoparticles (AuNPs): a new frontier in vaccine delivery. J Nanomedine Biotherapeutic Discov 5:4. https://doi.org/10.4172/2155-983X.1000e139
Dalrymple BP, Casu RE, Peters JM, Dimmock CM, Gale KR, Boese R, Wright IG (1993) Characterisation of a family of multi-copy genes encoding rhoptry protein homologues in Babesia bovis, Babesia ovis and Babesia canis. Mol Biochem Parasitol 57:181–192. https://doi.org/10.1016/0166-6851(93)90194-3
Dykman LA (2020) Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases. Expert Rev Vaccines 19:464–477. https://doi.org/10.1080/14760584.2020.1758070
Dykman LA, Staroverov SA, Bogatyrev VA, Shchyogolev SY (2010) Adjuvant properties of gold nanoparticles. Nanotechnol Russ 5:748–761. https://doi.org/10.1134/S1995078010110029
Dykman LA, Khlebtsov NG (2017a) Immunological properties of gold nanoparticles. Chem Sci 8:1719–1735. https://doi.org/10.1039/C6SC03631G
Dykman LA, Khlebtsov NG (2017b) Gold nanoparticles in biomedical applications. CRC Press, Boca Raton
Dykman LA, Khlebtsov NG (2019) Methods for chemical synthesis of colloidal gold. Russ Chem Rev 88:229–247. https://doi.org/10.1070/RCR4843
Eichenberger RM, Štefanić S, Naucke TJ, Šarkūnas M, Zamokas G, Grimm F, Deplazes P (2017) An ELISA for the early diagnosis of acute canine babesiosis detecting circulating antigen of large Babesia spp. Vet Parasitol 243:162–168. https://doi.org/10.1016/j.vetpar.2017.06.030
Facciolà A, Visalli G, Laganà P, La Fauci V, Squeri R, Pellicanò GF, Nunnari G, Trovato M, Di Pietro A (2019) The new era of vaccines: the “nanovaccinology.” Eur Rev Med Pharmacol Sci 23:7163–7182. https://doi.org/10.26355/eurrev_201908_18763
Furuta PI, Oliveira TM, Teixeira MC, Rocha AG, Machado RZ, Tinucci-Costa MG (2009) Comparison between a soluble antigen-based ELISA and IFAT in detecting antibodies against Babesia canis in dogs. Rev Bras Parasitol Vet 18:41–45. https://doi.org/10.4322/rbpv.01803007
Jalovecka M, Sojka D, Ascencio M, Schnittger L (2019) Babesia life cycle—when phylogeny meets biology. Trends Parasitol 35:356–368. https://doi.org/10.1016/j.pt.2019.01.007
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. https://doi.org/10.1038/227680a0
Lehtinen LE, Birkenheuer AJ, Droleskey RE, Holman PJ (2008) In vitro cultivation of a newly recognized Babesia sp. in dogs in North Carolina. Vet Parasitol 151:150–157. https://doi.org/10.1016/j.vetpar.2007.10.022
Leiter EH (1997) The NOD mouse: a model for insulin dependent diabetes mellitus. Curr Protoc Immunol 24:15.9.1-15.9.23. https://doi.org/10.1002/0471142735.im1509s24
Livanova NN, Fomenko NV, Akimov IA, Ivanov MJ, Tikunova NV, Armstrong R, Konyaev SV (2018) Dog survey in Russian veterinary hospitals: tick identification and molecular detection of tick-borne pathogens. Parasit Vectors 11:591. https://doi.org/10.1186/s13071-018-3161-5
Martinod S, Laurent N, Moreau Y (1986) Resistance and immunity of dogs against Babesia canis in an endemic area. Vet Parasitol 19:245–254. https://doi.org/10.1016/0304-4017(86)90072-5
Matijatko V, Torti M, Schetters TP (2012) Canine babesiosis in Europe: how many diseases? Trends Parasitol 28:99–105. https://doi.org/10.1016/j.pt.2011.11.003
Molinar E, James MA, Kakoma I, Holland C, Ristic M (1982) Antigenic and immunogenic studies on cell culture-derived Babesia canis. Vet Parasitol 10:29–40. https://doi.org/10.1016/0304-4017(82)90004-8
Moreau Y, Vidor E, Bissuel G, Dubreuil N (1989) Vaccination against canine babesiosis: an overview of field observations. Trans R Soc Trop Med Hyg 83:95–96. https://doi.org/10.1016/0035-9203(89)90611-1
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63. https://doi.org/10.1016/0022-1759(83)90303-4
Moubri K, Kleuskens J, Van de Crommert J, Scholtes N, Van Kasteren T, Delbecq S, Carcy B, Précigout E, Gorenflot A, Schetters T (2018) Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection. Vet Parasitol 249:21–29. https://doi.org/10.1016/j.vetpar.2017.11.002
Nocard E, Motas C (1902) Contribution à l’étude de la piroplasmose canine. Ann Inst Pasteur 16:257–290
Piana GP, Galli-Valerio B (1895) Su di un’ infezione del cane con parasiti endoglobulari. Mod Zooiatro 6:163–169
Salazar-González JA, González-Ortega O, Rosales-Mendoza S (2015) Gold nanoparticles and vaccine development. Expert Rev Vaccines 14:1197–1211. https://doi.org/10.1586/14760584.2015.1064772
Schetters TPM, Scholtes NC, Kleuskens JAGM, Bos HJ (1996) Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis. Parasite Immunol 18:1–6. https://doi.org/10.1046/j.1365-3024.1996.d01-1.x
Schetters TPM, Moubri K, Précigout E, Kleuskens J, Scholtes NC, Gorenflot A (1997) Different Babesia canis isolates, different diseases. Parasitology 115:485–493. https://doi.org/10.1017/S0031182097001686
Schetters T (2005) Vaccination against canine babesiosis. Trends Parasitol 21:179–184. https://doi.org/10.1016/j.pt.2005.02.006
Sibinovic KH, Sibinovic S, Ristic M, Cox HW (1967) Immunogenic properties of babesial serum antigens. J Parasitol 53:1121–1129. https://doi.org/10.2307/3276666
Tao W, Gill HS (2015) M2e-immobilized gold nanoparticles as influenza A vaccine: role of soluble M2e and longevity of protection. Vaccine 33:2307–2315. https://doi.org/10.1016/j.vaccine.2015.03.063
Tewari AK, Mishra AK, Rao JR (2000) Isolation and purification of cationic proteins from microaerophilous stationary phase culture supernatants of Babesia bigemina. J Appl Anim Res 18:41–48. https://doi.org/10.1080/09712119.2000.9706322
Uilenberg G (2006) Babesia––a historical overview. Vet Parasitol 138:3–10. https://doi.org/10.1016/j.vetpar.2006.01.035
Vijayan V, Mohapatra A, Uthaman S, Park I-K (2019) Recent advances in nanovaccines using biomimetic immunomodulatory materials. Pharmaceutics 11:534. https://doi.org/10.3390/pharmaceutics11100534
Wahlang L, Lakshmanan B, Thomas N, Bosewell A, Sunanda JJK, Aravindakshan TV (2019) Comparative analysis of conventional and real time PCR for detection of haemoparasites in dogs. Indian J Biotechnol 18:9–15
Wang P, Song J, Song R, Zhang M, Wu L, Li F, Yan Y, Zhou J, Chahan B, Liao M (2019) Preparation of monoclonal antibodies against Bc48 and development of a rapid detection assay for infection with Babesia caballi in China. Folia Parasit 66:005. https://doi.org/10.14411/fp.2019.005
White MW, Suvorova ES (2018) Apicomplexa cell cycles: something old, borrowed, lost, and new. Trends Parasitol 34:759–771. https://doi.org/10.1016/j.pt.2018.07.006
Wieser SN, Schnittger L, Florin-Christensen M, Delbecq S, Schetters T (2019) Vaccination against babesiosis using recombinant GPI-anchored proteins. Int J Parasitol 49:175–181. https://doi.org/10.1016/j.ijpara.2018.12.002
Yabsley MJ, Shock BC (2012) Natural history of Zoonotic Babesia: role of wildlife reservoirs. Int J Parasitol Parasites Wildl 2:18–31. https://doi.org/10.1016/j.ijppaw.2012.11.003
Yang Y-S, Murciano B, Moubri K, Cibrelus P, Schetters T, Gorenflot A, Delbecq S, Roumestand C (2012) Structural and functional characterization of Bc28.1, major erythrocyte–binding protein from Babesia canis merozoite surface. J Biol Chem 287:9495–9508. https://doi.org/10.1074/jbc.M111.260745
Zhou M, Cao S, Luo Y, Liu M, Wang G, Moumouni PFA, Jirapattharasate C, Iguchi A, Vudriko P, Terkawi MA, Löwenstein M, Kern A, Nishikawa Y, Suzuki H, Igarashi I, Xuan X (2016) Molecular identification and antigenic characterization of a merozoite surface antigen and a secreted antigen of Babesia canis (BcMSA1 and BcSA1). Parasit Vectors 9:257. https://doi.org/10.1186/s13071-016-1518-1
We thank Mr. D.N. Tychinin for his help in preparation of the manuscript.
This work was supported by the Russian Science Foundation (Grant no. 19-14-00077).
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Staroverov, S.A., Fomin, A.S., Kozlov, S.V. et al. Immune Response of Mice Against Babesia canis Antigens is Enhanced When Antigen is Coupled to Gold Nanoparticles. Acta Parasit. (2020). https://doi.org/10.1007/s11686-020-00305-z
- Babesia canis
- Gold nanoparticles
- Protective immunity